Plain-English translation of NCT06841796 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a continuous glucose monitor called Stelo can help people with prediabetes prevent or delay type 2 diabetes. The monitor tracks your blood sugar in real time, which may help you make better choices about food and exercise. Researchers want to see if seeing your glucose levels instantly helps you stick with healthy habits better than traditional diabetes prevention programs.
Many people with prediabetes don't complete traditional prevention programs, and most don't reach the lifestyle goals (weight loss, regular exercise, and healthy eating) needed to prevent diabetes. This trial is testing whether real-time glucose feedback from the monitor gives people a more powerful, personalized reason to stay motivated and make changes.
If you join, you'll wear a continuous glucose monitor (like a small patch on your skin) and receive support from a health coach at the YMCA, similar to a diabetes prevention program but enhanced with real-time glucose feedback. The study lasts 24 weeks (about 6 months), with check-ins at 6, 12, and 24 weeks. One group will wear the active Stelo monitor throughout, while the control group will wear a blinded monitor (that doesn't show readings) at specific timepoints to help researchers compare results.
AI-generated summary from trial data · Sep 3, 2026 · Not medical advice
United States